The international intravitreal bevacizumab safety survey.

about

Subfoveal choroidal thickness changes in carotid cavernous fistula following spontaneous resolution Intravitreal ranibizumab and bevacizumab: a review of risk.Parametric color coding of digital subtraction angiography in the evaluation of carotid cavernous fistulas.

P2860

Q36031440-B9E935DE-7B99-4E41-9F75-A87393CBA610 Q36925652-50629EAE-1F46-4014-9E49-FBB645D468CD Q40080320-E0A03EA1-4C45-43B5-8B8B-DE28A5CF2436

P2860

The international intravitreal bevacizumab safety survey.

Item

http://www.wikidata.org/entity/Q42841120

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

The international intravitreal bevacizumab safety survey.

@en

The international intravitreal bevacizumab safety survey.

@nl

type

Item

label

The international intravitreal bevacizumab safety survey.

@en

The international intravitreal bevacizumab safety survey.

@nl

prefLabel

The international intravitreal bevacizumab safety survey.

@en

The international intravitreal bevacizumab safety survey.

@nl

P1476

The international intravitreal bevacizumab safety survey.

@en

P2093

F Ziemssen

http://www.w3.org/2001/XMLSchema#string

K U Bartz-Schmidt

http://www.w3.org/2001/XMLSchema#string

S Grisanti

http://www.w3.org/2001/XMLSchema#string

P2860

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.

Detecting adverse events using information technology

Multiplicity of medication safety terms, definitions and functional meanings: when is enough enough?

Detecting adverse events for patient safety research: a review of current methodologies.

The quality of published adverse drug event reports.

Follow-up by mail in clinical trials: does questionnaire length matter?

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Measurement and expression of risk: optimizing decision strategies.

Masked hypertension: how can the condition be detected?

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

P304

1440-1441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.2006.098723

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17057183

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

1857465

http://www.w3.org/2001/XMLSchema#string

The international intravitreal bevacizumab safety survey.

about

P2860

P2860

The international intravitreal bevacizumab safety survey.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932